AKT1 and metabolic dysfunction-associated steatotic liver disease: According to the review by Riordan and Nadeau,PI3K/AKT signalling, JAK/STAT signalling, PPAR signalling, and NF-κB signalling are important pathways whose dysregulation plays a significant role in progression of NAFLD (9).